Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

17.15
+0.92005.67%
Post-market: 17.150.00000.00%19:30 EDT
Volume:218.39K
Turnover:3.65M
Market Cap:637.02M
PE:-2.31
High:17.19
Open:16.39
Low:16.03
Close:16.23
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:1.33
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:8.78
PE(LYR):-1.34

Loading ...

Aug 01, 2022

Major Issues Report

8-K - Current report
Aug 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 11, 2022

Major Issues Report

8-K - Current report
Jul 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 27, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 17, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 09, 2022

Major Issues Report

8-K - Current report
May 25, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 24, 2022

Major Issues Report

8-K/A [Amend] - Current report
May 23, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 02, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 21, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 05, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]